Sandra J Horning

Sandra J Horning

UNVERIFIED PROFILE

Are you Sandra J Horning?   Register this Author

Register author
Sandra J Horning

Sandra J Horning

Publications by authors named "Sandra J Horning"

Are you Sandra J Horning?   Register this Author

78Publications

1479Reads

26Profile Views

A new cancer ecosystem.

Authors:
Sandra J Horning

Science 2017 03;355(6330):1103

Sandra J. Horning is the Chief Medical Officer and Global Head of Product Development at Genentech and Roche, South San Francisco, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aan1295DOI Listing
March 2017

Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.

J Clin Oncol 2015 Jun 20;33(17):1936-42. Epub 2015 Apr 20.

Ranjana H. Advani, Richard T. Hoppe, and Sandra J. Horning, Stanford University, Stanford; Joseph M. Tuscano, University of California, Davis Cancer Center, Sacramento, CA; Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Richard I. Fisher and Jonathan W. Friedberg, University of Rochester, Rochester, NY; Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO; K. Sue Robinson, Queen Elizabeth II Health Science Center, Halifax, Nova Scotia; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia; Douglas A. Stewart, Tim Baker Cancer Institute, Calgary, Alberta, Canada; Henry Wagner Jr, Penn State Cancer Institute, Hershey, PA; Patrick J. Stiff, Loyola University Medical Center, Maywood; Leo I. Gordon, Northwestern University, Chicago, IL; Bruce D. Cheson, Georgetown University Hospital, Washington, DC; Brad S. Kahl, University of Wisconsin, Madison, WI; Kristie A. Blum, Ohio State University, Columbus, OH; and Thomas M. Habermann, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/04/15/JCO.2014.57
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.8138
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.8138DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451176PMC
June 2015

Anxiety and health-related quality of life among patients with low-tumor burden non-Hodgkin lymphoma randomly assigned to two different rituximab dosing regimens: results from ECOG trial E4402 (RESORT).

J Clin Oncol 2015 Mar 20;33(7):740-8. Epub 2015 Jan 20.

Lynne I. Wagner and David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL; Fengmin Zhao, Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Michael E. Williams, University of Virginia, Charlottesville, VA; John C. Krauss, University of Michigan, Ann Arbor, MI; Ranjana H. Advani, Stanford University, Stanford; Sandra J. Horning, Genentech, South San Francisco, CA; Ronald S. Go, Gunderson Health System, La Crosse; Brad S. Kahl, University of Wisconsin, Madison, WI; Thomas M. Habermann, Mayo Clinic, Rochester; Joseph W. Leach, Metro Minnesota Community Clinical Oncology Program, Minneapolis, MN; Brian O'Connor, Frederick Memorial Health System, Frederick, MD; Stephen J. Schuster, University of Pennsylvania, Philadelphia, PA; and Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/33/7/740.full.pdf
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.57.6801
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.57.6801DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334777PMC
March 2015

Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402.

J Clin Oncol 2014 Oct 25;32(28):3096-102. Epub 2014 Aug 25.

Brad S. Kahl, University of Wisconsin, Madison; Christopher G. Peterson, Aspirus Regional Cancer Center, Wausau; Matthias Weiss, Marshfield Clinic, Marshfield, WI; Fangxin Hong, Dana-Farber Cancer Institute, Boston, MA; Michael E. Williams, University of Virginia, Charlottesville, VA; Randy D. Gascoyne, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Lynne I. Wagner, Northwestern University, Chicago, IL; John C. Krauss, University of Michigan, Ann Arbor, MI; Thomas M. Habermann, Mayo Clinic, Rochester; Mark D. Sborov, Fairview-Southdale Hospital, St Louis Park, MN; Lode J. Swinnen, Johns Hopkins University, Baltimore, MD; Stephen J. Schuster, University of Pennsylvania, Philadelphia; W. Christopher Ehmann, Penn State Cancer Institute, Hershey, PA; S. Eric Martin, Christiana Care Community Clinical Oncology Program and Helen F. Graham Cancer Network, Newark, DE; and Sandra J. Horning, Genentech, South San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.5853DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171355PMC
October 2014

Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma.

J Clin Oncol 2014 Mar 10;32(9):912-8. Epub 2014 Feb 10.

Ranjana H. Advani, Sandra J. Horning, Richard T. Hoppe, Sarah Daadi, John Allen, and Yasodha Natkunam, Stanford University Medical Center, Stanford, CA; and Nancy L. Bartlett, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.53.2069DOI Listing
March 2014

Long-term outcomes after high dose therapy and autologous haematopoietic cell rescue for refractory/relapsed Hodgkin lymphoma.

Br J Haematol 2012 Nov 12;159(3):329-39. Epub 2012 Sep 12.

Department of Radiation Oncology, Stanford University, Palo Alto, CA, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/bjh.12038
Publisher Site
http://dx.doi.org/10.1111/bjh.12038DOI Listing
November 2012

Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.

Int J Radiat Oncol Biol Phys 2011 Dec 8;81(5):1374-9. Epub 2010 Oct 8.

Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2010.07.041DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020265PMC
December 2011

Utility of influenza vaccination for oncology patients.

J Clin Oncol 2010 May 12;28(14):2481-90. Epub 2010 Apr 12.

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.26.6908DOI Listing
May 2010

Immunoglobulin G Fc receptor FcgammaRIIIa 158 V/F polymorphism correlates with rituximab-induced neutropenia after autologous transplantation in patients with non-Hodgkin's lymphoma.

J Clin Oncol 2010 Jan 23;28(2):279-84. Epub 2009 Nov 23.

Division of Blood and Marrow Transplantation, 300 Pasteur Dr, Rm H3249, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.0274DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815716PMC
January 2010

Cancer research and privacy: the problem with being joined at the hip.

Authors:
Sandra J Horning

J Clin Oncol 2009 Aug 20;27(24):3879-80. Epub 2009 Jul 20.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.23.6695DOI Listing
August 2009

Risk, cure and complications in advanced hodgkin disease.

Authors:
Sandra J Horning

Hematology Am Soc Hematol Educ Program 2007 :197-203

Stanford University, 875 Blake Wilbur Drive, Suite CC-2338, Stanford, CA 94305-5821, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2007.1.197DOI Listing
July 2009

Hodgkin lymphoma in older patients: an uncommon disease in need of study.

Oncology (Williston Park) 2008 Nov;22(12):1369-79

Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA.

View Article

Download full-text PDF

Source
November 2008

Follicular lymphoma, survival, and rituximab: is it time to declare victory?

Authors:
Sandra J Horning

J Clin Oncol 2008 Oct 28;26(28):4537-8. Epub 2008 Jul 28.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.16.1398DOI Listing
October 2008

Follicular lymphoma: clinical features and treatment.

Hematol Oncol Clin North Am 2008 Oct;22(5):863-82, viii

Department of Hematology, Singapore General Hospital, Outram Road, Singapore 169608.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.07.013DOI Listing
October 2008

Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.

Biol Blood Marrow Transplant 2008 Jul;14(7):741-7

Stanford University Medical Center, Division of Blood and Marrow Transplantation, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2008.04.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980839PMC
July 2008

Follow-up of adult cancer survivors: new paradigms for survivorship care planning.

Authors:
Sandra J Horning

Hematol Oncol Clin North Am 2008 Apr;22(2):201-10, v

Stanford University, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2008.01.005DOI Listing
April 2008

Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497.

Leuk Lymphoma 2007 Dec 13;48(12):2397-402. Epub 2007 Oct 13.

Feinberg School of Medicine-Northwestern University, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190701694186DOI Listing
December 2007

Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.

J Clin Oncol 2007 Sep 30;25(25):3902-7. Epub 2007 Jul 30.

Stanford University Comprehensive Cancer Center, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.11.9867DOI Listing
September 2007

Angioimmunoblastic T cell lymphoma: treatment experience with cyclosporine.

Leuk Lymphoma 2007 Mar;48(3):521-5

Stanford University Medical Center, Stanford, CA 94305-5821, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190601137658DOI Listing
March 2007

Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.

J Clin Oncol 2007 Jan;25(1):43-9

Department of Medicine, Division of Cardiology, Stanford University Medical Center, Stanford, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.0805DOI Listing
January 2007

ASCO core values: essential to progress in innovative, quality cancer care.

Authors:
Sandra J Horning

J Clin Oncol 2006 Dec;24(36):5629

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.09.3286DOI Listing
December 2006

Burkitt's lymphoma--the message from microarrays.

N Engl J Med 2006 Jun;354(23):2495-8

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe068075DOI Listing
June 2006

Management of advanced stage Hodgkin lymphoma.

J Natl Compr Canc Netw 2006 Mar;4(3):241-7

Stanford University Medical Center, Stanford, California 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2006.0023DOI Listing
March 2006

Serving interests in hematologic malignancies in the journal of clinical oncology.

J Clin Oncol 2005 Jun;23(16):3666-7

Georgetown University, Washington, DC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.03.001DOI Listing
June 2005

Efficacy and safety of tositumomab and iodine-131 tositumomab (Bexxar) in B-cell lymphoma, progressive after rituximab.

J Clin Oncol 2005 Feb 21;23(4):712-9. Epub 2004 Dec 21.

Stanford University, Stanford, CA 94305-5821, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.07.040DOI Listing
February 2005

Optimizing rituximab in B-cell lymphoma.

Authors:
Sandra J Horning

J Clin Oncol 2005 Feb 18;23(6):1056-8. Epub 2005 Jan 18.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.09.924DOI Listing
February 2005

Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484.

J Clin Oncol 2004 Aug 21;22(15):3032-8. Epub 2004 Jun 21.

Stanford University, 875 Blake Wilbur Dr, Suite 2338, Stanford, CA 94305-5821, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.06.088DOI Listing
August 2004

Rituximab in stem cell transplantation for aggressive lymphoma.

Curr Hematol Rep 2004 Jul;3(4):227-9

Oncology and Bone Marrow Transplantation, Stanford University, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
July 2004

Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.

J Clin Oncol 2004 Apr 15;22(8):1454-9. Epub 2004 Mar 15.

Division of Oncology, Department of Medicine, Stanford University Medical Center, 875 Blake Wilber Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.10.086DOI Listing
April 2004

Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

Blood 2004 Feb 7;103(3):777-83. Epub 2003 Aug 7.

Division of Oncology, Stanford University Medical Center, Ste 202, 1000 Welch Rd, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2003-04-1257DOI Listing
February 2004

Future directions in radioimmunotherapy for B-cell lymphoma.

Authors:
Sandra J Horning

Semin Oncol 2003 Dec;30(6 Suppl 17):29-34

Division of Oncology, Stanford University School of Medicine, Palo Alto, Ca 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2003.10.006DOI Listing
December 2003

Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.

Blood 2003 Jun 13;101(11):4285-9. Epub 2003 Feb 13.

Department of Medicine, Stanford University School of Medicine, Stanford, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-08-2644DOI Listing
June 2003

Lymphocyte predominant Hodgkin's disease: more patience than patients.

Cancer J 2002 Sep-Oct;8(5):367-8

Department of Medicine, Stanford University School of Medicine, California 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/00130404-200209000-00005DOI Listing
April 2003

Introduction.

Authors:
Sandra J Horning

Semin Oncol 2003 Feb;30(1S2):1-2

Department of Medicine, Divisions of Oncology and Bone Marrow Transplantation, Stanford University School of Medicine, Stanford, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2003.50036DOI Listing
February 2003

Something old, something few, something subjective, something déjà vu.

Authors:
Sandra J Horning

J Clin Oncol 2003 Jan;21(1):1-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2003.18.114DOI Listing
January 2003

Lymphocyte predominant Hodgkin's disease.

Curr Oncol Rep 2002 Sep;4(5):424-33

Division of Oncology, Department of Medicine, Stanford University School of Medicine, 1000 Welch Road, Suite 202, Palo Alto, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-002-0037-8DOI Listing
September 2002

Hodgkin's disease.

Blood Rev 2002 Jun;16(2):111-7

Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1054/blre.2002.0190DOI Listing
June 2002

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

J Clin Oncol 2002 Feb;20(3):630-7

Department of Medicine, Division of Medical Oncology, Stanford University Medical Center, Stanford, CA 94304, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2002.20.3.630DOI Listing
February 2002